Intra-ocular expression of vascular endothelial growth factor (VEGF) and pigment epithelial-derived factor (PEDF) in a case of Eales’ disease by immunohistochemical analysis: a case report
- 95 Downloads
We report a immunohistochemical study of expression of VEGF and PEDF in Eales’ disease. An enucleated eye from a patient with Eales’ disease and an age and sex-matched donor eyeball were subjected to immunohistochemical and histopathological analysis to study the expression of VEGF and PEDF in the retinal region. Strong positive anti-VEGF immunostaining was found around the vessel walls in the retina in the eyeball from the Eales’ disease patient compared with the donor control, from which it was almost absent. PEDF staining was detected in the normal donor eyeball retinal layers surrounding the blood vessels, and the photoreceptor and ganglion cell layer, whereas in the eyeball from Eales’ disease patient PEDF staining was restricted to the surrounding blood vessels. The strong expression of VEGF in eyes with Eales’ disease as opposed to weak expression of PEDF indicates the propensity of the disease to show neovascularization and recurrent hemorrhages.
KeywordsEales’ disease Hypoxia Immunohistochemistry Pigment-derived growth factor (PEDF) Vascular endothelial growth factor (VEGF) Vasopermeability factor
We are extremely grateful for the antibody gifted by Dr Tombaran Tink and Dr Barnstable, Department of Ophthalmology and Visual science, Yale University, USA. This work is supported by the Vision Research Foundation, Chennai, India.
- 6.Haas TL, Milkiewicz M, Davis SJ, Zhou AL, Egginton S, Brown MD, Madri JA, Hudlicka O (2009) Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle. Am J Physiol Heart Circ Physiol 279:H1540–H1547Google Scholar
- 11.Takahashi H, Tamaki Y, Ishii N, Oikawa N, Mizuguchi E, Francis JH, Inoue Y, Iriyama A, Obata R, Yanagi Y (2008) Identification of a novel vascular endothelial growth factor receptor 2 inhibitor and its effect for choroidal neovascularization in vivo. Curr Eye Res 33:1002–1010CrossRefPubMedGoogle Scholar
- 12.Patel JI, Tombran-Tink J, Hykin PG, Gregor ZJ, Cree IA (2006) Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles. Exp Eye Res 82:798–806CrossRefPubMedGoogle Scholar
- 13.Yokoi M, Yamagishi S, Saito A, Yoshida Y, Matsui T, Saito W, Hirose S, Ohgami K, Kase M, Ohno S (2007) Positive association of pigment epithelium-derived factor (PEDF) with total anti-oxidant capacity in the vitreous fluid of patients with proliferative diabetic retinopathy. Br J Ophthalmol 91:885–887CrossRefPubMedGoogle Scholar
- 14.Rajesh M, Sulochana KN, Ramakrishnan S, Biswas J, Manoharan PT (2004) Iron chelation abrogates excessive formation of hydroxyl radicals and lipid peroxidation products in monocytes of patients’ with Eales’ disease: direct evidence using Electron Spin Resonance Spectroscopy. Curr Eye Res 28:399–407CrossRefPubMedGoogle Scholar